Sol-Gel receives Nasdaq compliance extension
On November 18, 2024, Sol-Gel Technologies Ltd., a company specializing in dermatological treatments, received an important extension regarding its compliance with Nasdaq’s listing requirements. The company was initially at risk of being delisted from the Nasdaq Global Market after its stock price remained below $1 for 33 consecutive business days. However, Nasdaq granted Sol-Gel an … Read more